Altogether, those studies, in conjunction with our study, seem to corroborate the idea that RAD51 is playing a too central and crucial role in homologous recombination and DSBs repair involving multiple pathways and complexes to tolerate deleterious germline variations and therefore contributes very little, if anything, to breast cancer susceptibility. This evidence concerns the gene RAD51 and breast cancer.